Pheophytin analogues from the medicinal lichen Usnea diffracta | |
Xu, Hong-Bo1; Yang, Tong-Hua2; Xie, Pei1; Liu, Shi-Jun1; Liang, Yan-Ni1; Zhang, Yu1; Song, Zhong-Xing1; Tang, Zhi-Shu1 | |
2018 | |
发表期刊 | NATURAL PRODUCT RESEARCH |
ISSN | 1478-6419 |
卷号 | 32期号:9页码:1088-1094 |
摘要 | A new pheophytin, (13(2)S, 17S, 18S)-13(2)-hydroxy-20-chloro-ethylpheophorbide a (3), along with two known analogues (1-2) were isolated from the lichen Usnea diffracta Vainio (Parmeliaceae). Among them, compound 3 was a rare C-20-chloro type pheophytin obtained from lichens. Their structures were elucidated by extensive spectroscopic analysis, and all the compounds were obtained for the first time from U. diffracta. Compounds (1-3) were evaluated for their xanthine oxidase (XO) inhibitory activities in vitro, and the results showed that 1-3 possessed significant enzyme inhibitory actions with IC50 values of 46.9 +/- 3.8, 75.9 +/- 7.4 and 42.1 +/- 1.7g/mL, respectively. |
关键词 | Usnea Diffracta Pheophytin Xanthine Oxidase |
DOI | 10.1080/14786419.2017.1380019 |
语种 | 英语 |
WOS记录号 | WOS:000426948000015 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/60533 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Shaanxi Univ Chinese Med, Shaanxi Collaborat Innovat Ctr Chinese Med Resour, Shaanxi Prov Key Lab New Drugs & Chinese Med Fdn, Xianyang, Peoples R China 2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China |
推荐引用方式 GB/T 7714 | Xu, Hong-Bo,Yang, Tong-Hua,Xie, Pei,et al. Pheophytin analogues from the medicinal lichen Usnea diffracta[J]. NATURAL PRODUCT RESEARCH,2018,32(9):1088-1094. |
APA | Xu, Hong-Bo.,Yang, Tong-Hua.,Xie, Pei.,Liu, Shi-Jun.,Liang, Yan-Ni.,...&Tang, Zhi-Shu.(2018).Pheophytin analogues from the medicinal lichen Usnea diffracta.NATURAL PRODUCT RESEARCH,32(9),1088-1094. |
MLA | Xu, Hong-Bo,et al."Pheophytin analogues from the medicinal lichen Usnea diffracta".NATURAL PRODUCT RESEARCH 32.9(2018):1088-1094. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论